Albert Nicholl
Chairman @Carcinotech
Signup · Get unlimited contacts
WORK HISTORY
Chairman @Carcinotech
Scotland, GB
ChairmanNami Surgical | Scotland · [Dates] – PresentCategory: Surgical Innovation | Precision Devices | MedTechAdvising on go-to-market strategy for minimally invasive surgical technologyMentoring CEO on operational structure, board-building, and institutional investor relationsSteering U.S. commercialisation roadmap and clinical validation strategyProviding governance through product refinement and early-stage capital milestones
EDUCATION
Glasgow Caledonian University
BA Business Studies, Finance Economics Law
The University of Edinburgh
Medieval French, French,Linguistics
SKILLS
ABOUT ALBERT NICHOLL
I support Scottish-founded healthtech ventures with global ambition, especially those aiming to scale into the U.S. market. My background as a senior executive at Stryker and Orthofix gives me deep operational insight into U.S. commercialisation, regulatory strategy, and market entry.Today, I chair and advise a portfolio of high-growth companies — Bioliberty, Nami Surgical, Carcinotech, Manus Neurodynamica, and SujiBFR — each solving real clinical problems through innovation in neurorehab, oncology, surgical robotics, and performance health. These are category-defining teams, backed by strong science and clear execution plans.I bring substantial fundraising experience, and I work closely with CEOs to shape strategy, build investor confidence, and guide companies through scaling, capital events, and U.S. traction. I pay particular attention to culture and leadership fit — because good ideas fail fast in the wrong hands.I actively support the High Growth Ventures initiative, the High-Growth Spinout Programme (HGSP), and Glasgow University’s MedTech Innovation Fund — all of which help bridge Scotland’s innovation with global impact.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.